GUD:TSE
Knight Therapeutics Inc
CA$10.68
arrow_downward
-1.39%(-0.15) 1D
Oct 13, 4:00:01 PM GMT-4 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GUD...
Open
CA$10.84
High
CA$10.84
Low
CA$10.65
Mkt. cap
1.05B
Avg. vol.
81.79K
Volume
93.74K
P/E ratio
71.21
52-wk high
CA$11.00
52-wk low
CA$5.66
EPS
CA$0.15
Beta
-0.07
Shares outstanding
98.23M
No. of employees
830
Open
CA$10.84
High
CA$10.84
Low
CA$10.65
Mkt. cap
1.05B
Avg. vol.
81.79K
Volume
93.74K
P/E ratio
71.21
52-wk high
CA$11.00
52-wk low
CA$5.66
EPS
CA$0.15
Beta
-0.07
Shares outstanding
98.23M
No. of employees
830
News stories
From web sources and news partners
Quiver Quantitative
·
40 minutes ago
Hecate Energy Appoints Michael J. Garofola as General Counsel Ahead of Planned Nasdaq Listing
NAI500
·
18 minutes ago
Agility Robotics On Track for November Nasdaq Listing as First U.S. Pure-Play Humanoid Robot Maker
Stock Titan
·
15 minutes ago
Delixy Holdings regains Nasdaq bid price compliance | DLXY SEC Filing - Form 6-K
AOL.com
·
40 minutes ago
The S&P 500 Is Dangerously Concentrated in 5 Tech Giants. Are They Still Buys?
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
HeadquartersMontreal, Quebec, Canada
SectorPharmaceutical industry
Websiteknighttx.com